Fresenius Seco Adr Stock Total Debt
| FREA Stock | EUR 8.10 0.05 0.61% |
FRESENIUS SECO ADR fundamentals help investors to digest information that contributes to FRESENIUS SE+CO's financial success or failures. It also enables traders to predict the movement of FRESENIUS Stock. The fundamental analysis module provides a way to measure FRESENIUS SE+CO's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to FRESENIUS SE+CO stock.
FRESENIUS |
FRESENIUS SECO ADR Company Total Debt Analysis
FRESENIUS SE+CO's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current FRESENIUS SE+CO Total Debt | 26.88 B |
Most of FRESENIUS SE+CO's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, FRESENIUS SECO ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, FRESENIUS SECO ADR has a Total Debt of 26.88 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Medical Care industry. The total debt for all Germany stocks is significantly lower than that of the firm.
FRESENIUS Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses FRESENIUS SE+CO's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of FRESENIUS SE+CO could also be used in its relative valuation, which is a method of valuing FRESENIUS SE+CO by comparing valuation metrics of similar companies.FRESENIUS SECO is currently under evaluation in total debt category among its peers.
FRESENIUS Fundamentals
| Return On Equity | 0.0793 | |||
| Return On Asset | 0.0292 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.09 % | |||
| Shares Outstanding | 2.25 B | |||
| Price To Earning | 12.47 X | |||
| Revenue | 40.16 B | |||
| Gross Profit | 10.26 B | |||
| EBITDA | 5.35 B | |||
| Net Income | 1.86 B | |||
| Cash And Equivalents | 1.46 B | |||
| Cash Per Share | 0.66 X | |||
| Total Debt | 26.88 B | |||
| Debt To Equity | 105.90 % | |||
| Current Ratio | 1.08 X | |||
| Book Value Per Share | 9.49 X | |||
| Cash Flow From Operations | 3.98 B | |||
| Earnings Per Share | 0.72 X | |||
| Number Of Employees | 319.69 K | |||
| Beta | 1.12 | |||
| Market Capitalization | 15.17 B | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 0.93 % | |||
| Last Dividend Paid | 0.92 |
About FRESENIUS SE+CO Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze FRESENIUS SECO ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of FRESENIUS SE+CO using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of FRESENIUS SECO ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in FRESENIUS Stock
FRESENIUS SE+CO financial ratios help investors to determine whether FRESENIUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in FRESENIUS with respect to the benefits of owning FRESENIUS SE+CO security.